Chiesi USA, Inc. recalls Revcovi (elapegademase-lvlr) Injection
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Failed Stability Specifications: Out of specification stability result for the protein concentration profile.
- Products
-
- Revcovi (elapegademase-lvlr) Injection
- Company
- Chiesi USA, Inc.
- Where it was sold
-
MO, TN
States: Missouri, Tennessee
- Units affected
- 3,002 vials
- About this recall
- Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-502-01